IL10 and neoplasm: As shown in Figure 4C, a delay in tumour growth was observed as long as anti‐IL‐10 or nor‐NOHA was administered, suggesting that BaF3‐RAE1ε MDSCs promote tumour growth in IL‐10‐ and arginase‐dependent manners.